Literature DB >> 21320582

SiRNA delivery with functionalized carbon nanotubes.

Amir Khashayar Varkouhi1, Stéphanie Foillard, Twan Lammers, Raymond M Schiffelers, Eric Doris, Wim E Hennink, Gert Storm.   

Abstract

Carbon nanotubes (CNTs) have been studied for drug, antigen and nucleic acid delivery both in vitro and in vivo. Due to their nano-needle structure, they are supposed to cross the plasma membrane and enter directly into the cytoplasm likely upon an endocytosis-independent mechanism without inducing cell death. In this study, two cationically functionalized CNTs (CNT-PEI and CNT-pyridinium) were investigated for siRNA delivery. Both functionalized CNTs complexed siRNA and showed 10-30% silencing activity and a cytotoxicity of 10-60%. However, in terms of reduced toxicity or increased silencing activity, CNT-PEI and CNT-pyridinium did not show an added value over PEI and other standard transfection systems. Probably, the type of functionalization of carbon nanotubes might be a key parameter to obtain an efficient and non-cytotoxic CNT-based delivery system. Nevertheless, in view of the present results and importantly also of the non-degradability of CNTs, preference should currently be given to designing biodegradable carriers which mimic the needle structure of CNTs.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320582     DOI: 10.1016/j.ijpharm.2011.02.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

1.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

2.  Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.

Authors:  Anish Babu; Anupama Munshi; Rajagopal Ramesh
Journal:  Drug Dev Ind Pharm       Date:  2017-05-19       Impact factor: 3.225

Review 3.  Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.

Authors:  Qi Liu; Xiang Wang; Tian Xia
Journal:  Anal Bioanal Chem       Date:  2018-08-01       Impact factor: 4.142

4.  Nanovectorization of DNA Through Cells Using Protamine Complexation.

Authors:  Khaoula Boukari; Cécile Caoduro; Raoudha Kacem; Nadia Skandrani; Christophe Borg; Hatem Boulahdour; Tijani Gharbi; Régis Delage-Mourroux; Eric Hervouet; Marc Pudlo; Fabien Picaud
Journal:  J Membr Biol       Date:  2016-03-24       Impact factor: 1.843

5.  siRNA Design and Delivery Based on Carbon Nanotubes.

Authors:  Danyang Li; Khuloud T Al-Jamal
Journal:  Methods Mol Biol       Date:  2021

6.  Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity.

Authors:  Ruibin Li; Xiang Wang; Zhaoxia Ji; Bingbing Sun; Haiyuan Zhang; Chong Hyun Chang; Sijie Lin; Huan Meng; Yu-Pei Liao; Meiying Wang; Zongxi Li; Angela A Hwang; Tze-Bin Song; Run Xu; Yang Yang; Jeffrey I Zink; André E Nel; Tian Xia
Journal:  ACS Nano       Date:  2013-02-28       Impact factor: 15.881

Review 7.  Carbon nanotubes part II: a remarkable carrier for drug and gene delivery.

Authors:  Mahdi Karimi; Navid Solati; Amir Ghasemi; Mehrdad Asghari Estiar; Mahshid Hashemkhani; Parnian Kiani; Elmira Mohamed; Ahad Saeidi; Mahdiar Taheri; Pinar Avci; Amir R Aref; Mohammad Amiri; Fazel Baniasadi; Michael R Hamblin
Journal:  Expert Opin Drug Deliv       Date:  2015-01-22       Impact factor: 6.648

Review 8.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

Review 9.  Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Authors:  Simeon K Adesina; Emmanuel O Akala
Journal:  Mol Pharm       Date:  2015-11-09       Impact factor: 4.939

Review 10.  Nanotechnology-based approaches in anticancer research.

Authors:  Nasimudeen R Jabir; Shams Tabrez; Ghulam Md Ashraf; Shazi Shakil; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  Int J Nanomedicine       Date:  2012-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.